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Hepatitis C virus (HCV) produces a chronic stimulation
to the immune system because of its marked lympho-
tropism and it has been suggested to be an etiological
agent of idiopathic pulmonary ¢brosis (IPF) (1). We re-
port, for the ¢rst time, the detection of HCV RNA in
the BAL of a patient a¡ected by pulmonary ¢brosis.
CASEREPORT
An 81-year-old woman, non-smoker, complaining of a 5-
year history of exertional dyspnea and a moderate dry
cough, was admitted to our respiratory unit forworsen-
ing clinical status and in particular for dyspnea at rest,
widespreadmuscleweakness, morning sti¡ness and pain
in the large joints. She had been a waitress and then
housewife, she has one sister a¡ected by chronic HCV
hepatitis. She never su¡ered from bronchopulmonary
diseases and she didnotreceive ¢brosis inducing therapy.
Physical examination
Poor nutritional status. The skin examination revealed
purpuric lesions and peripheral edema on the legs. The
large joints (hands, wrists, knees) were swollen, hot and
painful, but no gross joint deformities were evident, ex-
cept for a modest radial deviation at the wrist. Neither
¢nger clubbing nor subcutaneous nodules were noted.
Thoracic auscultation revealed crackles at both lung
bases.
The blood tests showed a peripheral leukocytosis
(white blood cells/mmc=18.5103) and increased levels
of the acute phase reactants.
A type II mixed cryoglobulinemia (Cryocrit 1%, IgM-
delta binding polyclonal IgG) with hypocomplementemiaReceived 20 August 2002, accepted in revised form 8 November 2002
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detected. All the liver functional parameterswere in the
normal range and the autoimmune panel (ANA, ENA,
ANCA) was negative.
The chest X-ray and thehigh-resolution computed to-
mography demonstrated a bilateral andperipheral thick-
ening of bronchovasal interstitiummore evident inupper
and lower lobes of the right lung (reticular pattern) with
subpleural honeycombing (Fig.1).ThehandsX-raydidnot
show cartilage erosion.
The spirometry pointed out a worse restrictive pat-
tern: VC (L) =1.18 (69.4%); RV (L)=0 .78 (65.4%); FEV1(L)=
1.12 (100%); FEV1/VC: 95%. Blood gas analysis (breathing
room air): pO2=63.2mmHg; pCO2=34.2mmHg;
pH=7.43.
The 6-minwalking test showed a reducedwalking dis-
tance (234m 57%); BORG max. 5; SatO2 min.: 87%
after the test.
The patient underwent a bronchoscopy (Pentax EB-
1830T2) with bronchoalveolar lavage in the middle lobe.
The bronchoscope was introduced by mouth, avoiding
suction. No endobronchial lesions were detected. The
procedure didnotprovokebleedingofbronchialmucosa.
The recovered £uid (45ml) was clear.Cytologic analy-
sis of BAL showed a lymphocytic-neutrophilic alveolitis
(cells/ml: 37104; macrophages: 56.3%; lymphocytes:
23%; neutrophils: 19.2%; eosinophils: 0.7%) (Fig. 2). The
study of the lymphocyte subsets (Facscan, Becton Dick-
inson) showeda highThelper/Tsuppressor ratio (CD3+: 53.1%;
CD3+CD4+: 36.1%; CD3+CD8+: 11.8%; CD4+/CD8+:
3.06,CD19+: 3.2%) and increased expression of activated
phenotypes (CD3+HLADR+: 82%; CD3+CD25+: 7.3%).
Thepatient had a subpopulation of double positiveT cells
(CD3+CD4+CD8+) in both the peripheral blood and
the BAL £uid (respectively, 6.2 and 3.2%). The BAL cul-
turewas negative.
Virological ¢ndings
The following virological analysis were performed:
HCVantibodies determination by enzyme immuno assay
(EIA), qualitative HCV RNA analysis by reverse
transcription polymerase chain reaction (RT-PCR) (2),
FIG. 1. HRCTshowingdi¡use reticular ¢brosiswith peripheralhoneycombing.
FIG. 2. Neutrophilic alveolitis in the BAL fromthe presented case.Magni¢cation 40.
HCVANDPULMONARYFIBROSIS 737quantitative HCVRNA analysis by b-DNA assay (Quan-
tiplex Versant 3.0 , Bayer, Eraigny, France), HCV
genotyping by HCV II Innolipa (Bayer, Eraigny, France).
Serum, bronchoalveolar lavage and saliva of the pa-
tient were analyzed. Serum anti-HCV antibodies were
detected and HCV genotypewas 2a/c.
For HCV RNA qualitative analysis serum, native un-
concentrated BAL and saliva were submitted to nucleicacid extraction by a commercial procedure (NucliSens
Isokit, bioMeŁ rieux, France). A 5ml volume of the ex-
tracted RNAwas used for RT-PCR, as described (3).
For quantitative analysis 50ml volume of serum and
BAL were used for b-DNA assay, as reccomended by
manufacturers.The viral load was expressed in Interna-
tional unit (IU)/ml by this quantitative test. In particular
1IU corresponds to 5.2 copies of HCV viral genome.
738 RESPIRATORYMEDICINEHCV RNA was found in serum and BAL, but not in
saliva, by RT-PCR.Quantitative analysis was performed
on positive samples, only. In particular,HCVRNA load in
serumwas 3 061600 IU/ml, whereas it was 6980 IU/ml in
BAL, by b-DNA.
Treatment and clinical evolution
The patient started treatment with prednisone 25mg/
day and hydroxychloroquine 400mg/day for 1 month
and 200mg/day for the next 2 months. Re-evaluation of
the clinical picture after 3 months of treatment showed
worsening dyspnea, increased lung ¢brosis assessed by
HRCT and a further decrease in lung volumes. In con-
trast, jointpain had improved, and the cryocrit andWaa-
ler-Rose tests had become negative.
DISCUSSION
This is the ¢rst documented case of isolation of HCV
genome in the BAL of a patient with pulmonary ¢brosis,
HCV infection and type II cryoglobulinemia. The main
limitation of microbiological assays of BAL is contamina-
tion of the £uid by oropharyngeal secretions or blood.
We, therefore, considered that it was essential to ex-
clude the presence of HCV in the saliva, which we did
by RT-PCR, and con¢rm that there were no traces of
blood in the cytological preparations of the BAL. In the
past Ferri et al. (2) isolated the genome of HCV in lung
biopsy specimens of a patient with desquamative inter-
stitial pneumonia, but in that case it was not possible to
exclude contamination of the tissues byblood during the
biopsy procedure, with consequent carriage of the virus
present in the blood.
The clinical data, the HRCT changes and the cytologi-
cal pro¢le of the BAL suggest a diagnosis of ‘‘idiopathic’’
pulmonary ¢brosis associatedwith a non-erosive arthri-
tis with a low titer positive rheumatoid factor, which is
commonly observed in cases of HCV-related cryoglobu-
linemia (4).
Apathogenic relationship between IPF andHCV infec-
tion has been supported by data from published studies
reporting that there is a higher frequency of anti-HCV
antibodies in patients with idiopathic pulmonary ¢brosis
(IPF) than in control populations (1^5), the presence of a
subclinical alveolitis in patients with HCV infectionwith-
out signs of lung damage (6^8) and anecdotal reports of
an association between HCV, cryoglobulinemia and var-
ious forms of interstitial lung diseases (9,10).The hypoth-
esis of a correlation between IPF and HCV infection
seems to be further strengthened by the isolation, for
the ¢rst time in a patient with lung ¢brosis, of the viral
genome in the BAL by RT-PCR. In a recentpaper, Idilman
et al. reported the detection of HCV in the BAL of a pa-
tient with chronic hepatitis C and subclinical alveolitisbut without clinical or radiological ¢ndings of interstitial
lungdisease (ILD) (8). Interestingly, our patient alsohad a
subpopulation of double positiveT cells in both the per-
ipheral blood and in the BALF. This population, charac-
terized by a CD4+CD8+ phenotype, has been
previously described in both healthy individuals and in
subjects infected by EBVor other viruses (11).
There arevarious possible origins of viral RNA in BAL
£uid: contamination by saliva or blood (both these possi-
bilities were excluded in our case), passive leakage from
theblood to the alveoli, transportvia infectedmononuc-
lear cells or active replication in the alveolarmicroenvir-
onment. The e¡ect of steroid therapy should also be
considered as a possible factor facilitating isolation of
thevirus, as hypothesized in a studybyKuwano et al. (12)
In conclusion, although it is di⁄cult to establish
whether the concomitant presence of IPF and HCV in-
fection is coincidental (both increase with age) or the
manifestation of a pathogenic link, the data from this sin-
gle case report seem to be consistent with the latter hy-
pothesis.
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